2018 Health Care & Life Sciences Investment Outlook
Healthcare and life sciences will face continued disruption in 2018 as new technologies emerge, economic pressures continue and consumer/patient demands evolve. KPMG and Leavitt Partners surveyed 265 corporate finance professionals about their thoughts about the industry and 12 separate sub-sectors
Healthcare & Life Sciences Institute Tue, 09 Jan 2018 00:00:00 GMT
Healthcare’s silver lining: The industry’s stance on the Cloud is transitioning from fear to optimism
Is your healthcare organization under pressure to transition to a value-based model? Considering a merger or acquisition to realize cost and time efficiencies? Struggling with outdated legacy EHR systems? Losing sleep over emerging cyber risks? If so, it’s time to give serious consideration to...
Healthcare & Life Sciences Institute Fri, 23 Feb 2018 00:00:00 GMT
Updating Medicare Parts C&D in response to market changes - The 2019 Medicare Part C&D Programs proposed rule
CMS issued a proposed rule for the Medicare Advantage and Part D programs that implements specific requirements in the Comprehensive Addiction and Recovery Act (CARA) and the 21st Century Cures Act (Cures).
Healthcare & Life Sciences Institute Wed, 10 Jan 2018 00:00:00 GMT
Advancing Payment Reform: Aligning MACRA payment model development with CMMI priorities
This paper explores the evolution of APMs since the passage of MACRA, examines barriers to new APM development and adoption, and raises questions about the limits of future APM proliferation.
Healthcare & Life Sciences Institute Mon, 26 Mar 2018 00:00:00 GMT
Pricing for Survival: As demand for pharmaceutical cost containment intensifies, novel drug-pricing approaches are critical
Specialty drug costs are so high that the entire pharmaceutical industry is now under scrutiny for its pricing practices. In this piece, we explore the practical approaches to pricing for value that pharma manufacturers can leverage today.
Healthcare & Life Sciences Institute Mon, 26 Feb 2018 00:00:00 GMT
Demystifying Blockchain for Life Sciences - Blockchain could be a key to interoperability and privacy
Life Sciences is facing an unprecedented amount of data stemming from wearable, electronic health records and patient claims data. Pending regulations such as General Data Protection Regulation (GDPR) will only increase the focus on data privacy.
Healthcare & Life Sciences Institute Fri, 09 Mar 2018 00:00:00 GMT
Wake Up Call: Healthcare providers and payers need to up their IT game. The clock is ticking
This whitepaper highlights the urgency for healthcare organizations to consider IT as a strategic priority in order to stay afloat in the midst of unimagined disruption and the need to maximize their IT investment strategies and optimize IT assets.
Healthcare & Life Sciences Institute Mon, 05 Mar 2018 00:00:00 GMT
The disruption challenge: As new entrants and cross-sector models abound, which direction should healthcare organizations turn?
The pace of disruptive healthcare deals today – and the dollar value they represent – will fundamentally change how healthcare will look in the future.
Healthcare & Life Sciences Institute Tue, 17 Apr 2018 00:00:00 GMT
Revenue for the Life Sciences Industry: New standard. New challenges.
The new standard introduces a core principle that requires companies to evaluate their transactions in a new way. This publication summarizes the most significant issues for the Life Sciences industry.
Healthcare & Life Sciences Institute Sat, 24 Feb 2018 00:00:00 GMT
What Works: The Triple Win - Rethinking Public Private Partnerships for Universal Healthcare
The time has come for universal health coverage (UHC); with unprecedented expansions in access to care across the world, global governments are looking to how private sector partners can contribute investment and skill to help them achieve it. Discover how to combine the lessons of the past...
Healthcare & Life Sciences Institute Thu, 22 Feb 2018 00:00:00 GMT
Future of Finance in Healthcare: Finance disrupted - As the industry adjusts to continuous disruption, the finance function has an opportunity to lead
The healthcare industry is experiencing unprecedented financial pressures in the midst of new and changing regulations, rising operating costs and reduced reimbursements for care delivery. CEOs are looking to the finance function to take on a considerably broader and deeper set of strategic...
Healthcare & Life Sciences Institute Thu, 26 Apr 2018 00:00:00 GMT
Future of Finance: Finance Disrupted - Innovation in the Life Sciences Finance Function
Today’s rapidly changing healthcare and life sciences ecosystem and business environment requires finance to address disruption head on or risk being left behind by more nimble competitors. Leading life sciences chief financial officers are focusing on turning disruption into opportunities for...
Healthcare & Life Sciences Institute Wed, 23 May 2018 00:00:00 GMT
The healthy approach to cyber security: For data-intensive healthcare, cyber security is integral to innovation
Find KPMG expert insights and the results of our healthcare cyber security survey here.
Healthcare & Life Sciences Institute Fri, 28 Jul 2017 00:00:00 GMT
Interoperability - The unfinished health IT agenda
Health IT systems and interoperability are critically important for optimizing performance and payment in the value-based healthcare environment. Indeed, as Vindell Washington, former National Coordinator for Health IT, and Andy Slavitt, former Acting Administrator of the Centers for Medicare...
Healthcare & Life Sciences Institute Mon, 15 May 2017 00:00:00 GMT
Relationship capital: The path to profitable growth through patient loyalty and provider productivity
Hospitals and health systems have a renewed focus on profitable organic growth. After decades spent developing their physical assets, implementing systems, and making acquisitions, executives are asking how they can best get a return on these capital outlays.
Healthcare & Life Sciences Institute Fri, 14 Jul 2017 00:00:00 GMT